| Primary |
| Hiv Infection |
66.7% |
| Human Immunodeficiency Virus Transmission |
33.3% |
|
| Small For Dates Baby |
28.6% |
| Drug Exposure During Pregnancy |
14.3% |
| Nephrolithiasis |
14.3% |
| Premature Baby |
14.3% |
| Retroviral Rebound Syndrome |
14.3% |
| Virologic Failure |
14.3% |
|
| Secondary |
| Hiv Infection |
73.1% |
| Antiretroviral Therapy |
5.8% |
| Drug Use For Unknown Indication |
4.0% |
| Drug Exposure During Pregnancy |
3.6% |
| Acquired Immunodeficiency Syndrome |
2.0% |
| Product Used For Unknown Indication |
1.8% |
| Pneumocystis Jiroveci Infection |
1.7% |
| Hiv Test Positive |
1.5% |
| Hepatitis C |
1.2% |
| Systemic Antiviral Treatment |
1.0% |
| Haemorrhage |
0.8% |
| Hypertension |
0.7% |
| Antiviral Prophylaxis |
0.5% |
| Coronary Artery Disease |
0.4% |
| Human Immunodeficiency Virus Transmission |
0.4% |
| Blood Cholesterol Increased |
0.3% |
| Blood Triglycerides Increased |
0.3% |
| Prophylaxis Against Diarrhoea |
0.3% |
| Factor Viii Deficiency |
0.3% |
| Hiv Infection Cdc Category C3 |
0.3% |
|
| Progressive External Ophthalmoplegia |
11.8% |
| Progressive Multifocal Leukoencephalopathy |
7.5% |
| Ophthalmoplegia |
6.5% |
| Osteonecrosis |
6.5% |
| Parkinsonism |
6.5% |
| Periarthritis |
6.5% |
| Vomiting |
6.5% |
| Drug Exposure During Pregnancy |
5.4% |
| Fallot's Tetralogy |
4.3% |
| Nephrolithiasis |
4.3% |
| Swelling |
4.3% |
| Varices Oesophageal |
4.3% |
| Insomnia |
3.2% |
| Myocardial Infarction |
3.2% |
| Splenomegaly |
3.2% |
| Virologic Failure |
3.2% |
| Visual Disturbance |
3.2% |
| Visual Impairment |
3.2% |
| Weight Increased |
3.2% |
| White Blood Cell Count Increased |
3.2% |
|
| Concomitant |
| Hiv Infection |
42.0% |
| Antiretroviral Therapy |
28.0% |
| Cd4 Lymphocytes Decreased |
6.4% |
| Hiv Test Positive |
4.5% |
| Drug Use For Unknown Indication |
3.8% |
| Coronary Artery Disease |
1.9% |
| Myocardial Ischaemia |
1.9% |
| Autism |
1.3% |
| Fungal Infection |
1.3% |
| Hyperlipidaemia |
1.3% |
| Hypertension |
1.3% |
| Tuberculosis |
1.3% |
| Vitamin Supplementation |
1.3% |
| Back Pain |
0.6% |
| Gout |
0.6% |
| Hypercholesterolaemia |
0.6% |
| Insomnia |
0.6% |
| Migraine |
0.6% |
| Pneumonia |
0.6% |
|
| Pain In Extremity |
13.8% |
| Vomiting |
10.3% |
| Hepatic Enzyme Increased |
6.9% |
| Leukoencephalopathy |
6.9% |
| Pregnancy |
6.9% |
| Urine Colour Abnormal |
6.9% |
| Coronary Artery Disease |
3.4% |
| Drug Interaction |
3.4% |
| Fallot's Tetralogy |
3.4% |
| Hyperlactacidaemia |
3.4% |
| Mental Disorder |
3.4% |
| Muscle Rigidity |
3.4% |
| Myocardial Infarction |
3.4% |
| Proteinuria |
3.4% |
| Pyrexia |
3.4% |
| Rash |
3.4% |
| Renal Tubular Atrophy |
3.4% |
| Rhabdomyolysis |
3.4% |
| Skin Reaction |
3.4% |
| Social Avoidant Behaviour |
3.4% |
|
| Interacting |
| Hiv Infection |
68.4% |
| Fungal Infection |
15.8% |
| Major Depression |
15.8% |
|
| Blood Hiv Rna Increased |
25.0% |
| Lethargy |
25.0% |
| Transaminases Increased |
25.0% |
| Virologic Failure |
25.0% |
|
